PK

Pankaj Kumar Rastogi

Director DIN 03645207
DIN 03645207 First appointment Nov 2011
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Pankaj Kumar Rastogi

Data last updated:

Pankaj Kumar Rastogi was a Director at Mamenza Pharmaceutical Private Limited (from 2011) and Director at Reinc Life Sciences Private Limited (from 2015).

DIN 03645207
First Appointment 01 Nov 2011
Oldest Company Age 15 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Nov 20112011Strike Off
Reinc Life Sciences Private Limited U24110PN2015PTC155330
Director08 Jun 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Mamenza Pharmaceutical Private Limited
Reinc Life Sciences Private Limited
Premium access

Shareholding and investment profile for Pankaj Kumar Rastogi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pankaj Kumar Rastogi

Pankaj Kumar Rastogi was first appointed on 01 Nov 2011 as Director at Mamenza Pharmaceutical Private Limited. The most recent appointment on record is 08 Jun 2015 at Reinc Life Sciences Private Limited.

Pankaj Kumar Rastogi held 2 earlier board appointments: Mamenza Pharmaceutical Private Limited (Director, from 01 Nov 2011); Reinc Life Sciences Private Limited (Director, from 08 Jun 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available